Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Four Device Makers Apply For 2011 New-Technology Add-On Bonus

This article was originally published in The Gray Sheet

Executive Summary

CMS has received five applications from four device firms for its next round of new-technology add-on payments, including submissions for two products that did not qualify for the extra payment during previous attempts

You may also be interested in...



CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter

Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO

CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter

Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO

Baxter Prepares To Launch TachoSil Surgical Sealant For Cardiac Surgery

Baxter plans a U.S. launch of TachoSil, a first-of-its-kind absorbable fibrin sealant patch for use in cardiovascular surgery, in the second half of 2010, following FDA approval of the combination device-biologic April 2

Related Content

Topics

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel